# clm_711CD08A7AE6

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 2,435,000,000 United States dollar  
valid_from: 2018-06-30  
valid_to: 2018-09-30  
published: 2018-07-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_45DDDCF11BF8  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 2,435,000,000 United States dollar", as of 2018-06-30 (until 2018-09-30). Claim clm_711CD08A7AE6, https://asof.is/claim/clm_711CD08A7AE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-07-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm (primary, SEC EDGAR 10-Q Q2 FY2018, published 2018-07-26)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,250,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_711CD08A7AE6](/claim/clm_711CD08A7AE6.md) | [clm_CE50CA7EBC72](/claim/clm_CE50CA7EBC72.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.